2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
8
Progesterone
6
Spironolactone
4
drospirenone and ethinyl estradiol combination
3
Inositol
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
Sugars
2
Folic Acid
2
Flutamide
2
Estradiol
2
Cyproterone Acetate
2
Clomiphene
2
maltodextrin
1
licogliflozin
1
bicalutamide
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Ultrasonography
1
Topiramate
1
Time
1
Thioctic Acid
1
Sodium Salicylate
1
Sex Characteristics
1
Physical Examination
1
Phlebotomy
1
Phenotype
1
Ovidrel
1
Magnesium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperandrogenism
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts